Literature DB >> 23778057

Serum uric acid in relation to serum 1,5-anhydroglucitol levels in patients with and without type 2 diabetes mellitus.

Motoshi Ouchi1, Kenzo Oba, Junya Aoyama, Kentaro Watanabe, Kazuhito Ishii, Hiroyuki Yano, Masayuki Motoyama, Ken-Ichi Sekimizu, Noriaki Matsumura, Yoshimasa Igari, Tatsuya Suzuki, Hiroshi Nakano.   

Abstract

OBJECTIVES: The aim of this study was to examine the relationship between serum levels of uric acid (UA) and 1,5-anhydroglucitol (1,5-AG) in elderly subjects (60 years or older; mean age, 73.0±7.2 years) with and without type 2 diabetes mellitus (DM).
METHODS: Subjects with DM (n=97) and without DM (n=360) were recruited from among our outpatients (estimated glomerular filtration rate≥45 mL min⁻¹ 1.73 m⁻², and urine protein equivalent to <1.0 g/L), and a cross-sectional study was performed with simple linear regression and stepwise multiple linear regression analyses.
RESULTS: The mean serum UA levels of men were significantly higher than those of women in both groups. The mean serum 1,5-AG levels of men were significantly higher than those of women in the non-DM group. There were positive correlations (indicated by Pearson's correlation coefficients) between serum UA levels and 1,5-anhydroglucitol levels in all patients and in both men and women. Simple linear regression and multiple linear regression analyses showed that the serum 1,5-AG levels were significantly and positively correlated with the serum UA level in both the non-DM group and the DM group. In the non-DM group, HbA1c levels, as well as 1,5-AG levels, were positively correlated with serum UA levels. Furthermore, the correlation between 1,5-AG and UA levels was stronger in subjects with DM than in subjects without DM.
CONCLUSIONS: These results suggest that the serum 1,5-AG level is an independent factor associated with serum UA levels in the nondiabetic state, as in DM.
Copyright © 2013 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  1,5-AG; 1,5-Anhydroglucitol; 1,5-anhydroglucitol; DM; FPG; GLUT9; Glucosuria; JDS; Japan Diabetes Society; NGSP; NGT; National Glycohemoglobin Standardization Program; Renal threshold; SGLT; SGLT2 inhibitor; SLC; UA; URAT1; Uric acid; diabetes mellitus; eGFR; estimated glomerular filtration rate; fasting plasma glucose; glucose transporter 9; normal glucose tolerance; sodium-glucose co-transporter; solute carrier; urate transporter 1; uric acid

Mesh:

Substances:

Year:  2013        PMID: 23778057     DOI: 10.1016/j.clinbiochem.2013.06.003

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  5 in total

1.  Understanding the role of SGLT2 inhibitors in glycogen storage disease type Ib: the experience of one UK centre.

Authors:  Rebecca K Halligan; R Neil Dalton; Charles Turner; Katherine A Lewis; Helen R Mundy
Journal:  Orphanet J Rare Dis       Date:  2022-05-12       Impact factor: 4.303

2.  Diagnostic value of glycemic markers HbA1c, 1,5-anhydroglucitol and glycated albumin in evaluating gestational diabetes mellitus.

Authors:  Baris Saglam; Sezer Uysal; Sadik Sozdinler; Omer Erbil Dogan; Banu Onvural
Journal:  Ther Adv Endocrinol Metab       Date:  2017-11-23       Impact factor: 3.565

3.  Uric acid lowering in relation to HbA1c reductions with the SGLT2 inhibitor tofogliflozin.

Authors:  Motoshi Ouchi; Kenzo Oba; Kohei Kaku; Hideki Suganami; Akihiro Yoshida; Yasunori Fukunaka; Promsuk Jutabha; Asuka Morita; Naoyuki Otani; Keitaro Hayashi; Tomoe Fujita; Tatsuya Suzuki; Masahiro Yasutake; Naohiko Anzai
Journal:  Diabetes Obes Metab       Date:  2018-01-08       Impact factor: 6.577

4.  Correlation of Serum 1,5-AG with Uric Acid in Type 2 Diabetes Mellitus with Different Renal Functions.

Authors:  Kai Zhang; Bizhen Xue; Yuexing Yuan; Yao Wang
Journal:  Int J Endocrinol       Date:  2019-03-06       Impact factor: 3.257

Review 5.  Hypothesis: A Novel Neuroprotective Role for Glucose-6-phosphatase (G6PC3) in Brain-To Maintain Energy-Dependent Functions Including Cognitive Processes.

Authors:  Gerald A Dienel
Journal:  Neurochem Res       Date:  2020-08-19       Impact factor: 3.996

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.